Navigation Links
Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process
Date:10/13/2010

h coronary artery disease.  In addition, consistent with its capital-efficient business model, Cardium continues to actively evaluate new technologies and business opportunities.  In July 2009, Cardium completed the sale of its InnerCool Therapies medical device business to Royal Philips Electronics, the first asset monetization from the Company's biomedical investment portfolio.  News from Cardium is located at www.cardiumthx.com.

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations.  For example, there can be no assurance that results or trends observed in one clinical study or procedure will be reproduced in subsequent studies or procedures, or that clinical studies even if successful will lead to product advancement or partnering; that the U.S. Food and Drug Administration will grant marketing clearance of our product candidates or that we or a partner can successfully introduce our products into advanced wound care markets; that our product candidates will be perceived as being sufficiently safe and effective to lead to product advancement or partnering; that our product candidates offer the potential for simpler or more cost-effective treatments for physicians and patients than other products that currently are or will be on the market; that FDA or other regulatory clearances or other certifications, or other commercialization efforts will be successful or will effectively enhance our businesses or its perceived value; that our products or product candidates will prove to be sufficiently safe and effective after introduction into a broader patient population; that discussions with potential str
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
4. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
5. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
6. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
7. Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
8. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
9. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
10. Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development
11. Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 3, 2015, order from the Federal Drug Administration (FDA) ... to clarify the drugs, intended use and warn about a ... protect the public from injury from these products, according to ... Conroy . The order says that the drug ... taken by millions of U.S. men – are approved only ...
(Date:3/4/2015)... , March 4, 2015 XBiotech ... pilot study in patients with moderate to severe ... The open-label Phase II trial evaluated the potential ... antibody that targets interleukin-1 alpha (IL-1a). IL-1a is ... cells present in skin lesions. The Company claims ...
(Date:3/4/2015)... Minn. , March 4, 2015   Mayo ... an agreement to develop the next generation of wearable ... "We are hoping that this technology will be game-changer. ... and diabetes," says James Levine, M.D., Ph.D. , ... "They are accurate, inexpensive, and can be integrated into ...
Breaking Medicine Technology:Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3
... Anti-Viral Applications of Novel Targeted Agents Under ... Technology Platform -, - Anti-Viral Potential of ... at American Association of Immunologists Annual Meeting -, ... PPHM ), a clinical stage biopharmaceutical,company developing monoclonal antibodies ...
... Cardinal Health, a,global provider of products and ... care, today announced that it will now manufacture,compound ... trials., The company,s new services for the ... of Nuclear Medicine,s (SNM) 55th Annual Meeting,taking place ...
Cached Medicine Technology:Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 2Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 3Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 4Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials 2
(Date:3/4/2015)... 04, 2015 Problem Gambling Awareness Month ... join individuals and organizations across the nation in this ... health care professionals, policymakers, and others about problem gambling ... Compulsive Gambling (FCCG) and FCCG partner organizations are calling ... patients for a gambling problem, to make treatment readily ...
(Date:3/4/2015)... Miami, FL (PRWEB) March 04, 2015 ... diet, is showing promise in terms of extending life. ... have shown that this new dieting routine can help ... through antioxidant production clearly has long term benefits, many ... side-effects, thus a quicker substitute is necessary. As an ...
(Date:3/4/2015)... Los Angeles (PRWEB) March 04, 2015 ... patented Cunermuspir complex, the world’s first biocompatible copper chelate, ... MitoSynergy will offer guests the chance to gain insight ... learn about how the Cunermuspir complex can support their ... chair. , Cunermuspir, which is the core ingredient of ...
(Date:3/4/2015)... 2015 Follow us on LinkedIn ... draw milk from the breast of a lactating mother through ... use for feeding the baby. Breast pumps are used when ... birth, or the mother being away from a child for ... others. Breast pumps are also used to stimulate lactation and ...
(Date:3/4/2015)... 04, 2015 Brassica Protection Products LLC, ... the rebrand of its SGS™ brand of glucoraphanin to ... percent glucoraphanin, which is the most concentrated source of ... initiative includes a new truebroc logo and refreshed website ... and brand name. , “We are thrilled to ...
Breaking Medicine News(10 mins):Health News:Problem Gambling - A Public Health Issue; March Is Problem Gambling Awareness Month 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 3Health News:MitoSynergy Invites Expo West Attendees to Sit Back, Relax and Take Time for Their Health 2Health News:Increase in the Number of Nursing Mothers in the Workplace Spurs the Breast Pumps Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Increase in the Number of Nursing Mothers in the Workplace Spurs the Breast Pumps Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Brassica Protection Products Rebrands its SGS™ Brand of Glucoraphanin to truebroc™ 2
... Corporation,(Nasdaq: PODD ), the leader in patch pump ... appointment of Sally W.,Crawford to its board of directors. ... operating officer of Healthsource Inc., a managed care,organization. She ... firm in life sciences, on Insulet,s board of directors., ...
... lost to HIV/AIDS in South Africa from 2000 and ... program was not implemented, assert researchers from the Harvard ... online by the Journal of Acquired Immune Deficiency ... estimated 35,000 babies were born with HIV during that ...
... Sechrist Industries, Inc.,announced that it has been ... Partners, L.P., the group purchasing unit of ... 2008 through September 30, 2010, allows,Sechrist to ... hospitals,and 53,000 additional healthcare sites., (Logo: ...
... work with federal and state health agencies,to increase ... themselves on MRSA and C. diff prevention, ... Authority supports "International Infection Prevention,Week," October 19-25, 2008 ... and the public from healthcare-associated infections., The ...
... Members Report Some Payers Scaling Back Chronic Disease,Initiatives, ... Continuum,Alliance, responding to reports that many Americans are ... called for renewed vigilance,in the fight against chronic ... some forms of belt-tightening make sense in tough ...
... Psychemedics,Corporation (Nasdaq: PMD ) today announced that Raymond ... Ray will be responsible for all internal and ... and planning,activities necessary for the company,s continued growth. Ray ... 2005, Ray has served as Director of International Finance ...
Cached Medicine News:Health News:Sally W. Crawford Joins Insulet's Board of Directors 2Health News:Sally W. Crawford Joins Insulet's Board of Directors 3Health News:Sally W. Crawford Joins Insulet's Board of Directors 4Health News:Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa 2Health News:Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa 3Health News:Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa 4Health News:Sechrist Industries, Inc. Awarded Premier Sole-Source Contract for Hyperbaric Oxygen Chambers 2Health News:Patient Safety Authority Supports 'International Infection Prevention Week' 2Health News:Patient Safety Authority Supports 'International Infection Prevention Week' 3Health News:Nation's Economic Downturn Threatens Continuity of Care for Chronic Conditions 2Health News:Raymond J. Ruddy Joins Psychemedics Corporation As Top Financial Officer 2
... The DexCom STS Continuous Glucose Monitoring System ... transmits blood glucose readings to the DexCom STS ... sensor which is inserted via the DexCom STS ... the skin where it is held in place ...
... Eclipse,Plus or 850 ECG medical ... capability. Doctors,maintain all the benefits ... and gain the,ability to view ... personal computers., With diagnostic-quality viewing ...
... For practices performing routine ... with QuickStep Wizard provides a,practical, ... tightly managed health care,environment. This ... available in a variety,of configurations ...
... that need an advanced ... Vision,Premier Holter System provides ... Vision Premier system,adds expanded ... comprehensive list of diagnostic,codes ...
Medicine Products: